Artificial Intelligence (AI) In Oncology Market
Artificial Intelligence (AI) In Oncology Market Size, Share & Trends Analysis Report By Component (Software, Hardware, And Services), By Cancer Type (Breast, Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, And Others), By Treatment Type (Into Chemotherapy, Radiation Therapy, Immunotherapy, And Others), And By Application (Cancer Detection, Drug Discovery, Drug Development, And Others), Forecast Period (2025-2035)
Artificial intelligence (AI) in oncology market was valued at $2.4 billion in 2024 and is projected to reach $42.8 billion by 2035, growing at a CAGR of 29.8% during the forecast period (2025-2035). The market is growing owing to the increasing demand for accurate cancer diagnosis and early treatment globally. AI algorithms can accurately analyze medical images and data, reducing the risk of human error in the detection and categorization of diseases such as HER2 in breast cancer. Treatment options can be implemented more effectively owing to this added accuracy. Sustained technological advancements by market players are driving market growth. For instance, in July 2023, PathAI introduced AIM-HER2 breast cancer, an artificial intelligence-based HER2 scoring algorithm for biopharma research and clinical laboratories. AIM-HER2 Breast Cancer visualizations on AISight leverage the strength of additive multiple instance learning (aMIL) heatmaps along with slide-level HER2 score prediction to present a more complete picture.
Segmental Outlook
The global oncology market for artificial intelligence (AI) is categorized by component, cancer type, treatment type, and application. On the component, the market is divided into software, hardware, and services. On the cancer type, the market is divided into breast cancer, lung cancer, prostate cancer, colorectal cancer, brain tumor, and others. Based on the type of treatment, the market is segmented into chemotherapy, radiation therapy, immunotherapy, and others. Additionally, based on application, the market is segmented into cancer detection, drug discovery, drug development, and others. The subcategory of software is anticipated to hold a major share of the market in the component segment. This can be credited to new entrepreneurial ventures that offer novel solutions to cancer therapy and prediction, supported by financing from leading industry players. For instance, in September 2023, cancer diagnosis technology startup Adela revealed it raised $48 million, taking its total raise to $108 million. The money will go towards developing the company's technology. Adela will also employ the proceeds towards commercializing its tissue-agnostic measurable residual disease (MRD) product and further building its multi-cancer early-detection product, both of which are developed on its methylation enrichment platform.
The Breast Cancer Sub-Segment is Anticipated to Hold a Considerable Share of the Global Artificial Intelligence (AI) in Oncology Market.
Among all the regions, the North American region, the US, is contributing the highest to the market. In 2022, demand for diagnosis and detection across the region was rising across the region. AI is being used to assess medical pictures, such as radiology and pathology slides. In addition to lowering the burden of cancer, this can considerably improve patient outcomes. According to the National Institute of Health (NIH), in June 2023, cancer is a major global public health issue, with 19.3 million new cases and 10 million deaths reported each year. The International Agency for Research on Cancer (IARC) has provided a poster listing known causes and preventive measures for cancer by organ site.
Regional Outlook
The Global AI in oncology market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Russia, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to grow at a considerable CAGR owing to an increasing number of older individuals and the rising incidence of cancer cases in the region. For instance, according to the National Institute of Health (NIH), in March 2023, GLOBOCAN predicted that cancer cases in India would increase to 2.08 million, accounting for a rise of 57.5% in 2040 from 2020.
The North American region is Leading in the Global Artificial Intelligence (AI) in Oncology Market.
Among all the regions, North America is expected to grow at a significant CAGR during the forecasted period. In 2022, owing to the increase in early detection and diagnosis in the region. To detect cancer at an earlier, more treatable stage, AI is utilized to scan medical images such as radiology and pathology slides. Apart from decreasing the cancer burden, this can significantly enhance patient outcomes. According to the National Institute of Health (NIH), in June 2023, Lung cancer is the leading cause of cancer-related mortality, with approximately 1.8 million deaths expected, followed by cancer of the stomach, liver, colorectal, and breast. In the US, cancer is the second major cause of mortality following heart disease, with an estimated 1.9 million new cancers and 609,820 fatalities owing to cancer in 2023. The International Agency for Research on Cancer (IARC) has made available a poster of known causes and prevention strategies for cancer by organ site.
Market Players Outlook
The major companies that are serving AI in the oncology market are Azra AI, Siemens Healthineers AG, GE HealthCare, NVIDIA Corp., and ConcertAI LLC., and others. The market players are significantly contributing to market growth by implementing various strategies such as mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to remain competitive in the market For instance, in September 2023, Microsoft and healthcare technology company Paige launched a partnership to create the largest image-based artificial intelligence (AI) models for digital pathology and oncology.
The Report Cover
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global AI in oncology market. Based on the availability of data, information related to new product launches and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies. Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. AI In Oncology Market Sales Analysis – Component |Cancer Type| Treatment Type| Application ($ Million)
1.2. Research Methodology
• Primary Research Approach
• Secondary Research Approach
1.3. Market Snapshot
2. Market Overview and Insights
2.1. Scope of the Study
2.2. Analyst Insight & Current Market Trends
2.2.1. Key AI In Oncology Industry Trends
2.2.2. Market Recommendations
2.2.3. Conclusion
3. Market Determinants
3.1. Market Drivers
3.2. Drivers For AI In Oncology Market: Impact Analysis
3.3. Market Pain Points and Challenges
3.4. Restraints For AI In Oncology Market: Impact Analysis
3.5. Market Opportunities
4. Competitive Landscape
4.1. Competitive Dashboard –AI In Oncology Market Revenue by Manufacturers
4.2. Key Company Analysis
4.2.1. Overview
4.2.2. Product Portfolio
4.2.3. Financial Analysis (Subject to Data Availability)
4.2.4. SWOT Analysis
4.2.5. Business Strategy
4.3. Top Winning Strategies by Market Players
4.3.1. Merger and Acquisition
4.3.2. Product Launch
4.3.3. Partnership And Collaboration
5. Global AI In Oncology Market by Component ($ Million)
5.1. Software
5.2. Hardware
5.3. Services
6. Global AI In Oncology Market by Cancer Type ($ Million)
6.1. Breast Cancer
6.2. Lung Cancer
6.3. Prostate Cancer
6.4. Colorectal Cancer
6.5. Brain Cancer
6.6. Others (Pancreatic Cancer, and Ovarian Cancer)
7. Global AI In Oncology Market by Treatment Type ($ Million)
7.1. Chemotherapy
7.2. Radiation Therapy
7.3. Immunotherapy
7.4. Others (Surgery, and Targeted Therapies)
8. Global AI in Oncology Market by Application
8.1. Cancer Detection
8.2. Drug Discovery
8.3. Drug Development
8.4. Others (Patient Education and Support, and Survivorship and Quality of Life Enhancement)
9. Regional Analysis
9.1. North American AI In Oncology Market Sales Analysis – Component |Cancer Type| Treatment Type | Application | Country ($ Million)
9.1.1. United States
9.1.2. Canada
9.2. European AI In Oncology Market Sales Analysis – Component |Cancer Type| Treatment Type | Application | Country ($ Million)
9.2.1. UK
9.2.2. Germany
9.2.3. Italy
9.2.4. Spain
9.2.5. France
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Asia-Pacific AI In Oncology Market Sales Analysis – Component |Cancer Type| Treatment Type | Application | Country ($ Million)
9.3.1. China
9.3.2. Japan
9.3.3. South Korea
9.3.4. India
9.3.5. Australia & New Zealand
9.3.6. ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And others)
9.3.7. Rest of Asia-Pacific
9.4. Rest of the World AI In Oncology Market Sales Analysis – Component |Cancer Type| Treatment Type | Application | Country ($ Million)
9.4.1. Latin America
9.4.2. Middle East and Africa
10. Company Profiles
10.1. Absci Corp.
10.2. Atomwise, Inc.
10.3. CureMetrix, Inc.
10.4. Deepcell, Inc.
10.5. Epigene Labs
10.6. Freenome Holdings, Inc
10.7. GE Healthcare
10.8. Grail, Inc
10.9. IBM Watson Health
10.10. Insilico Medicine, Inc
10.11. Koninklijke Philips N.V
10.12. Lunit Inc.
10.13. Manas AI
10.14. Oncora Medical, Inc
10.15. Owkin, Inc.
10.16. Paige.AI, Inc
10.17. Philips Healthcare
10.18. Proscia Inc.
10.19. Siemens Healthineers AG
10.20. Tempus AI, Inc.
1. Global AI In Oncology Market Research And Analysis By Component, 2024-2035 ($ Million)
2. Global AI Software In Oncology Market Research And Analysis By Region, 2024-2035 ($ Million)
3. Global AI Hardware In Oncology Market Research And Analysis By Region, 2024-2035 ($ Million)
4. Global AI Services In Oncology Market Research And Analysis By Region, 2024-2035 ($ Million)
5. Global AI In Oncology Market Research And Analysis By Cancer Type, 2024-2035 ($ Million)
6. Global AI In Breast Cancer Market Research And Analysis By Region, 2024-2035 ($ Million)
7. Global AI In Lung Cancer Market Research And Analysis By Region, 2024-2035 ($ Million)
8. Global AI In Prostate Cancer Market Research And Analysis By Region, 2024-2035 ($ Million)
9. Global AI In Colorectal Cancer Market Research And Analysis By Region, 2024-2035 ($ Million)
10. Global AI In Brain Cancer Market Research And Analysis By Region, 2024-2035 ($ Million)
11. Global AI In Other Cancer Market Research And Analysis By Region, 2024-2035 ($ Million)
12. Global AI In Oncology Market Research And Analysis By Treatment Type, 2024-2035 ($ Million)
13. Global AI In Chemotherapy Oncology Market Research And Analysis By Region, 2024-2035 ($ Million)
14. Global AI In Radiation Therapy Oncology Market Research And Analysis By Region, 2024-2035 ($ Million)
15. Global AI In Immunotherapy Oncology Market Research And Analysis By Region, 2024-2035 ($ Million)
16. Global AI In Other Oncology Treatment Type Market Research And Analysis By Region, 2024-2035 ($ Million)
17. Global AI In Oncology Market Research And Analysis By Application, 2024-2035 ($ Million)
18. Global AI In Cancer Detection Market Research And Analysis By Region, 2024-2035 ($ Million)
19. Global AI In Drug Discovery Market Research And Analysis By Region, 2024-2035 ($ Million)
20. Global AI In Drug Development Market Research And Analysis By Region, 2024-2035 ($ Million)
21. Global AI In Other Application Market Research, And Analysis By Region, 2024-2035 ($ Million)
22. Global AI In Oncology Market Research And Analysis By Region, 2024-2035 ($ Million)
23. North America AI In Oncology Market Research And Analysis By Country, 2024-2035 ($ Million)
24. North American AI In Oncology Market Research And Analysis By Component, 2024-2035 ($ Million)
25. North American AI In Oncology Market Research And Analysis By Cancer Type, 2024-2035 ($ Million)
26. North American AI In Oncology Market Research And Analysis By Treatment Type, 2024-2035 ($ Million)
27. North American AI In Oncology Market Research And Analysis By Application, 2024-2035 ($ Million)
28. European AI In Oncology Market Research And Analysis By Country, 2024-2035 ($ Million)
29. European AI In Oncology Market Research And Analysis By Component, 2024-2035 ($ Million)
30. European AI In Oncology Market Research And Analysis By Treatment Type, 2024-2035 ($ Million)
31. European AI In Oncology Market Research And Analysis By Cancer Type, 2024-2035 ($ Million)
32. European AI In Oncology Market Research And Analysis By Application, 2024-2035 ($ Million)
33. Asia-Pacific AI In Oncology Market Research And Analysis By Country, 2024-2035 ($ Million)
34. Asia-Pacific Artificial Intelligence (AI) In Oncology Market Research And Analysis By Component, 2024-2035 ($ Million)
35. Asia-Pacific Artificial Intelligence (AI) In Oncology Market Research And Analysis By Cancer Type, 2024-2035 ($ Million)
36. European AI In Oncology Market Research And Analysis By Treatment Type, 2024-2035 ($ Million)
37. Asia-Pacific Artificial Intelligence (AI) In Oncology Market Research And Analysis By Application, 2024-2035 ($ Million)
38. Rest Of The World AI In Oncology Market Research And Analysis By Region, 2024-2035 ($ Million)
39. Rest Of The World AI In Oncology Market Research And Analysis By Component, 2024-2035 ($ Million)
40. Rest Of The World AI In Oncology Market Research And Analysis By Treatment Type, 2024-2035 ($ Million)
41. Rest Of The World AI In Oncology Market Research And Analysis By Cancer Type, 2024-2035 ($ Million)
42. Rest Of The World AI In Oncology Market Research And Analysis By Application, 2024-2035 ($ Million)
1. Global AI In Oncology Market Share By Component, 2024 Vs 2035 (%)
2. Global AI Software In Oncology Market Share By Region, 2024 Vs 2035 (%)
3. Global AI Hardware In Oncology Market Share By Region, 2024 Vs 2035 (%)
4. Global AI Services In Oncology Market Share By Region, 2024 Vs 2035 (%)
5. Global AI In Oncology Market Share By Cancer Type, 2024 Vs 2035 (%)
6. Global AI In Breast Cancer Market Share By Region, 2024 Vs 2035 (%)
7. Global AI In Lung Cancer Market Share By Region, 2024 Vs 2035 (%)
8. Global AI In Prostate Cancer Market Share By Region, 2024 Vs 2035 (%)
9. Global AI In Colorectal Cancer Market Share By Region, 2024 Vs 2035 (%)
10. Global AI In Brain Cancer Market Share By Region, 2024 Vs 2035 (%)
11. Global AI In Other Cancer Market Share By Region, 2024 Vs 2035 (%)
12. Global AI In Oncology Market Share By Treatment Type, 2024 Vs 2035 (%)
13. Global AI In AI In Chemotherapy Oncology Market Share By Region, 2024 Vs 2035 (%)
14. Global AI In Radiation Therapy Oncology Market Share By Region, 2024 Vs 2035 (%)
15. Global AI In Immunotherapy Oncology Market Share By Region, 2024 Vs 2035 (%)
16. Global AI In Other Oncology Treatment Type Market Share By Region, 2024 Vs 2035 (%)
17. Global AI In Oncology Market Share By Application, 2024 Vs 2035 (%)
18. Global AI In Cancer Detection Market Share By Region, 2024 Vs 2035 (%)
19. Global AI In Drug Discovery Market Share By Region, 2024 Vs 2035 (%)
20. Global AI In Drug Development Market Share By Region, 2024 Vs 2035 (%)
21. Global AI In Oncology Other Application Market Share By Region, 2024 Vs 2035 (%)
22. Global AI In Oncology Market Share By Region, 2024 Vs 2035 (%)
23. US AI In Oncology Market Size, 2024-2035 ($ Million)
24. Canada AI In Oncology Market Size, 2024-2035 ($ Million)
25. UK AI In Oncology Market Size, 2024-2035 ($ Million)
26. France AI In Oncology Market Size, 2024-2035 ($ Million)
27. Germany AI In Oncology Market Size, 2024-2035 ($ Million)
28. Italy AI In Oncology Market Size, 2024-2035 ($ Million)
29. Spain AI In Oncology Market Size, 2024-2035 ($ Million)
30. Russia AI In Oncology Market Size, 2024-2035 ($ Million)
31. Rest of Europe AI In Oncology Market Size, 2024-2035 ($ Million)
32. India AI In Oncology Market Size, 2024-2035 ($ Million)
33. China AI In Oncology Market Size, 2024-2035 ($ Million)
34. Japan AI In Oncology Market Size, 2024-2035 ($ Million)
35. South Korea AI In Oncology Market Size, 2024-2035 ($ Million)
36. Australia And New Zealand AI In Oncology Market Size, 2024-2035 ($ Million)
37. ASEAN AI In Oncology Market Size, 2024-2035 ($ Million)
38. Rest Of Asia-Pacific AI In Oncology Market Size, 2024-2035 ($ Million)
39. Rest Of The World AI In Oncology Market Size, 2024-2035 ($ Million)
FAQS
The size of the Artificial Intelligence (AI) In Oncology market in 2024 is estimated to be around $2.4 billion.
North America holds the largest share in the Artificial Intelligence (AI) In Oncology market.
Leading players in the Artificial Intelligence (AI) In Oncology market include Azra AI, Siemens Healthineers AG, GE HealthCare, NVIDIA Corp., and ConcertAI LLC., and others.
Artificial Intelligence (AI) In Oncology market is expected to grow at a CAGR of 29.8% from 2025 to 2035.
Rising cancer prevalence, advancements in AI, and demand for precision oncology are driving the growth of the AI in Oncology Market.